![Douglas Giordano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Giordano
Direktor/Vorstandsmitglied bei
PANACEA ACQUISITION CORP. II
Vermögen: - $ am 30.09.2026
Profil
Mr. Douglas E.
Giordano is an Independent Director at Panacea Acquisition Corp.
II, a Managing Director & Perceptive Discovery Co-Head at Perceptive Advisors (Private Equity), an Advisor at New Rhein Healthcare Investors, a Member-Visitors Board at Duke University School of Medicine and a President & Director at FoldRx Pharmaceuticals LLC.
He is on the Board of Directors at Panacea Acquisition Corp.
II, Cerevel Therapeutics LLC, Cerevel Therapeutics, Inc., ViiV Healthcare Ltd. and FoldRx Pharmaceuticals LLC.
Mr. Giordano was previously employed as an Independent Non-Executive Director by Kardigan, Inc., a President, Treasurer & Director by Array BioPharma, Inc., an Independent Director by Cerevel Therapeutics Holdings, Inc., a President, Treasurer & Director by Medivation LLC (California), a Chief Executive Officer by Anacor Pharmaceuticals LLC, a Vice President by Icagen, Inc., a President by Encysive Pharmaceuticals, Inc., a Senior VP-Worldwide Business Development by Pfizer Inc., and a President by Serenex, Inc. He also served on the board at ICU Medical, Inc., Zoetis, Inc., KP Pharmaceuticals LLC and Viatris, Inc. He received his undergraduate degree from Duke University and an MBA from Johnson Graduate School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 18.06.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
Aktive Positionen von Douglas Giordano
| Unternehmen | Position | Beginn |
|---|---|---|
| PANACEA ACQUISITION CORP. II | Direktor/Vorstandsmitglied | 06.04.2021 |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Direktor/Vorstandsmitglied | - |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Berater | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Private Equity Investor | 01.04.2021 |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cerevel Therapeutics LLC
 Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs to treat disorders of central nervous system | Direktor/Vorstandsmitglied | - |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktor/Vorstandsmitglied | 01.06.2012 |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Präsident | - |
Ehemalige bekannte Positionen von Douglas Giordano
| Unternehmen | Position | Ende |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 01.08.2024 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Douglas Giordano
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
22
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 22 |
|---|---|
ICU Medical, Inc.
 ICU Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and sells medical technologies | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Serenex, Inc.
 Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Health Technology |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Health Technology |
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zoetis, Inc.
 Zoetis, Inc. Pharmaceuticals: MajorHealth Technology Develops animal vaccines and prescriptions medicines | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Finance |
Cerevel Therapeutics LLC
Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs to treat disorders of central nervous system | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Health Technology |
Panacea Acquisition Corp. II
 Panacea Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
